Hospital Agostino Gemelli   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Rome Italy (1964)

Organization Overview

First Clinical Trial
2016
NCT04201769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fondazione Policlinico Universitaria A. Gemelli IRCCS | Fondazione Policlinico universitario a. Gemelli | Fondazione Policlinico Universitario A. Gemelli IRCCS | Fondazione Policlinico Universitario A. Gemelli IRCCS. Largo A. Gemelli 8, 00168 Rome, Italy. | Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UCSC - Rome (Italy) | Fondazione Policlinico Universitario "A. Gemelli" IRCCS - UOC Oncologia Medica, Rome | Fondazione Policlinico Universitario Agostino Gemelli | Gemelli Hospital, Universidad Cattolica del Sacro Cuore, Roma (Italia) | Hospital Agostino Gemelli | IRCCS Fondazione Policlinico A. Gemelli | Universitario Agostino Gemelli | VENTO GIOVANNI

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Nausea (Phase 3)

Pulmonary Valve Insufficiency (Phase 2)

Respiratory Insufficiency (Phase 2)

Surgical Wound Infection (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 18